Balchem Corporation (BCPC)

Market Cap	5.57B +7.2%
Revenue (ttm)	1.04B +8.8%
Net Income	154.85M +20.5%
EPS	4.75 +20.9%
Shares Out	32.03M
PE Ratio	36.59
Forward PE	30.56
Dividend	$0.96 (0.55%)
Ex-Dividend Date	Dec 23, 2025

Volume	399,023
Open	176.29
Previous Close	176.53
Day's Range	171.57 - 176.51
52-Week Range	139.17 - 183.90
Beta	0.95
Analysts	Buy
Price Target	176.00 (+1.28%)
Earnings Date	Apr 30, 2026

About BCPC

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended ...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1967
• Employees: 1,352
• Stock Exchange: NASDAQ
• Ticker Symbol: BCPC
• Website: https://www.balchem.com

Financial Performance

In 2025, Balchem's revenue was $1.04 billion, an increase of 8.75% compared to the previous year's $953.68 million. Earnings were $154.85 million, an increase of 20.53%.

Analyst Summary

According to 2 analysts, the average rating for BCPC stock is "Buy." The 12-month stock price target is $176.0, which is an increase of 1.28% from the latest price.

Price Target

$176.0

(1.28% upside)

Analyst Consensus: Buy